Jack Moore, the owner of The Book Review in Rochester’s Hillcrest Shopping Center, delivered the news on social media on ...

Gil Blum, an analyst from Needham, maintained the Buy rating on Autolus Therapeutics (AUTL – Research Report). The associated price ...

The Great Impersonator” unfortunately relies a bit too much upon the rawness of its themes alone, letting its technical ...

Syndax (SNDX) announced that multiple abstracts evaluating revumenib, an oral small molecule menin inhibitor, have been accepted for oral ...

Penny’s 19th installment in the beloved Gamache series is a particularly haunting and relevant mystery novel. Yael van der Wouden’s novel, shortlisted for this year’s Booker Prize, is about ...

Although polycythemia vera management remains focused on reducing the risk of thrombotic events, there is growing recognition ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Wirecutter Staff The OXO Brew 9 Cup Coffee Maker is now our top-pick ...

Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, ...

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

Kruppel-like factor 4 (KLF4) is a transcription factor that plays pivotal roles in various physiological and pathophysiological processes, such as wound healing and cancer development, by regulating ...